PRESS RELEASES
2026-10-29 07:45 Prolight secures two additional European patents for Psyros®
2026-10-28 08:00 Prolight receives first order of approximately SEK 19.9 million from BRAINBox
Read more
FINANCIAL REPORTS
All financial reports

The future of Point of Care Analysis – Right Here, Right Now

Prolight Diagnostics has developed a breakthrough point-of-care platform that delivers reliable test results in 10 minutes or less, right at the patient’s side.

 

Driving efficiency and accelerating time to clinical decision.

Watch the video to discover why our proprietary, patent-protected technology is at the heart of the next major shift in healthcare.

 
Play Video

Prolight Diagnostics develops innovative Point-of-Care (POC) systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood.

 

POC tests are performed outside the traditional hospital laboratory, for example in an emergency department, ambulance, healthcare centre or nursing home. POC tests are generally easier to perform than central lab tests and do not require complex training.

Prolight's novel digital technology may be the start of a paradigm shift in POC testing

Established analogue POC technology

- currently used by all other products

  • Intensity measurement across the bulk sample
  • Analytica signal blends into to the background
  • Background noise limits signal-to-noise
  • Challenge to measure low concentration levels

New digital POC technology

- only used on the Psyros™ platform

  • Single molecule counting
  • Thresholding determines if the signal is on or off
  • No background noise
  • Enables measurement of ultra-low concentration levels

Did you know?

  • No other existing POC system can offer single molecule counting with such simplicity, precision, and low cost of production.
  • Our unique proprietary, single molecule counting (digital) POC system can detect extremely low levels of troponin.
  • Our IP-protected POC system meets every stringent requirement set by the market.
  • Only a small drop of blood is required to perform the test, even for multiplexed tests, where more than one analyte is measured simultaneously.
  • Our ground-breaking digital technology that detects and counts single molecules could see the beginning of a paradigm shift within POC testing.
About Prolight

Ground-breaking ultra-sensitive technology

The novel Psyros® digital (single molecule counting) technology provides the opportunity to develop new ultra-sensitive POC tests in many clinical areas previously limited to specialized laboratories.

Future applications across many diverse clinical areas:

What is unique about Psyros®?